U.S. Physical Therapy, Inc. reported $214 million in Revenue for Q2 2026, marking an 8.5% increase from last year, though it fell short of the $0.86 EPS consensus estimate with Earnings of $0.75. For investors, this growth indicates continued market demand, offsetting the earnings miss amidst increasing operational costs.
Key Highlights
- U.S. Physical Therapy, Inc. (NYSE: USPH) achieved total revenue of $214 million for the second quarter of 2026, reflecting an 8.5% growth compared to the prior year.
- Physical therapy revenue reached $182 million in Q2, which is an 8.4% increase year-over-year.
- The company's Gross Profit Margin for physical therapy in Q2 2026 stood at 19.9%, down from 21.4% a year ago.
U.S. Physical Therapy, Inc. (NYSE: USPH) achieved total revenue of $214 million for the second quarter of 2026, reflecting an 8.5% growth compared to the prior year. The company experienced strong operational dynamics, driven by a notable increase in clinic visit volumes. In a comparative context, U.S. Physical Therapy's EPS for the quarter was $0.75, falling short of the $0.86 consensus estimate, which might influence market perceptions despite the revenue growth.
Strong Demand for physical therapy services supports this upward trend, highlighting the resilience of the Business model in a competitive healthcare environment.
Revenue Growth Driven by High Clinic Volumes
Physical therapy revenue reached $182 million in Q2, which is an 8.4% increase year-over-year. The average daily visits per clinic also set a new record at 33.5. U.S. Physical Therapy benefited significantly from its hospital affiliations, contributing $5.6 million to revenue as it transitioned additional clinics.
The increase in clinic volumes translates to a strong foothold within the outpatient therapy sector, indicating potential for greater profitability going forward. Given the rising demand for health services, this expansion could further improve performance metrics in upcoming quarters.
Rising Operational Costs and Their Impact
The company's gross profit margin for physical therapy in Q2 2026 stood at 19.9%, down from 21.4% a year ago. This decline is attributed to above-average self-insured healthcare costs, which increased by approximately $3.2 million compared to last year. Hiring costs related to new clinician onboarding, under hospital affiliation agreements, have also affected profit margins.
However, the reimbursement structure for licensed staff under these agreements allows for strategic investments in staffing without jeopardizing the bottom line. This operational strategy signals a commitment to growth despite current cost challenges, positioning the company for recovery as these clinics fully transition.
Solid Year-to-Date Performance
U.S. Physical Therapy's stock has appreciated 3.6% year-to-date and has surged 12.7% over the past month, showcasing market confidence in its operational strategies and revenue growth. The effective management of partnerships and aggressive recruitment of new clinicians bolsters the company's outlook as it heads toward 2027. With guidance indicating a projected increase in Medicare revenue for the next year, sustained performance across its platforms suggests that investors should monitor the ongoing integration of hospital-forged affiliations.
Analysts will be looking for continued upward momentum in both revenue and Volume metrics during the next quarterly report.
Investors will be keenly awaiting U.S. Physical Therapy's next conference call for further insights on growth strategies and clinic performance metrics.
Peers Moving on This News
- Nutex Health Inc (NUTX) little changed
- Ardent Health Inc (ARDT) up 2.0%
- Sonida Senior Living Inc (SNDA) little changed
Analysis based on the Form 8-K filed 10 August 2026; figures verified against the filing and live market data.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making Investment decisions.






Please wait processing your request...